While there is strong interest to develop FAP targeting anti-cancer strategies for the clinic [43, 46–49, 66–68], it is of concern that studies looking at off-tumour effects of FAP-targeting regimens have yielded mixed results [26, 46, 47, 69–72]. Here, FAP is linked to cancer.